| Basics |
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
|
| IPO Date: |
July 11, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$12.43B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.74 | 1.92%
|
| Avg Daily Range (30 D): |
$2.77 | 1.37%
|
| Avg Daily Range (90 D): |
$2.96 | 1.58%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.15M |
| Avg Daily Volume (30 D): |
.38M |
| Avg Daily Volume (90 D): |
.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
67 |
| Avg Trade Size (Sh.) (30 D): |
45 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Inst.Trades: |
3,779 |
| Avg Inst. Trade: |
$3.51M |
| Avg Inst. Trade (30 D): |
$4.88M |
| Avg Inst. Trade (90 D): |
$5.44M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.23M |
| Avg Closing Trade (30 D): |
$5.64M |
| Avg Closing Trade (90 D): |
$5.67M |
| Avg Closing Volume: |
24.71K |
|
|
|
|
|
